TY - JOUR PY - 2006 DA - 2006// TI - A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Part II : Immunization of adults JO - MMWR VL - 55 ID - ref1 ER - TY - JOUR AU - Porgo, T. V. AU - Gilca, V. AU - Serres, G. AU - Tremblay, M. AU - Skowronski, D. PY - 2015 DA - 2015// TI - Dramatic reduction in hepatitis B through school-based immunization without a routine infant program in a low endemicity region JO - BMC Infect Dis VL - 15 UR - https://doi.org/10.1186/s12879-015-0979-8 DO - 10.1186/s12879-015-0979-8 ID - Porgo2015 ER - TY - BOOK PY - 2015 DA - 2015// TI - Viral Hepatitis Surveillance. United States, 2013 PB - Centers for Disease Control and Prevention CY - Atlanta ID - ref3 ER - TY - BOOK AU - Venne, S. AU - Lambert, G. AU - Blouin, K. PY - 2013 DA - 2013// TI - Portrait des infections transmissibles sexuellement et par le sang (ITSS) au Québec PB - INSPQ CY - Québec ID - Venne2013 ER - TY - JOUR AU - Möller, B. AU - Hopf, U. AU - Stemerowicz, R. AU - Henze, G. AU - Gelderblom, H. PY - 1989 DA - 1989// TI - HBcAg expressed on the surface of circulating Dane particles in patients with hepatitis B virus infection without evidence of anti-HBc formation JO - Hepatology VL - 10 UR - https://doi.org/10.1002/hep.1840100210 DO - 10.1002/hep.1840100210 ID - Möller1989 ER - TY - BOOK PY - 2015 DA - 2015// TI - Protocole d’immunisation du Québec PB - Ministère de la santé et des services sociaux du Québec CY - Québec ID - ref6 ER - TY - JOUR AU - Pondé, R. A. PY - 2011 DA - 2011// TI - The underlying mechanisms for the “isolated positivity for the hepatitis B surface antigen (HBsAg)” serological profile JO - Med Microbiol Immunol VL - 200 UR - https://doi.org/10.1007/s00430-010-0160-3 DO - 10.1007/s00430-010-0160-3 ID - Pondé2011 ER - TY - JOUR AU - Avettand-Fenoel, V. AU - Thabut, D. AU - Katlama, C. AU - Poynard, T. AU - Thibault, V. PY - 2006 DA - 2006// TI - Immune suppression as the etiology of failure to detect anti-HBc antibodies in patients with chronic hepatitis B virus infection JO - J Clin Microbiol VL - 44 UR - https://doi.org/10.1128/JCM.00234-06 DO - 10.1128/JCM.00234-06 ID - Avettand-Fenoel2006 ER - TY - JOUR AU - Bhat, R. A. AU - Ulrich, P. P. AU - Vyas, G. N. PY - 1990 DA - 1990// TI - Molecular characterization of a new variant of hepatitis B virus in a persistently infected homosexual man JO - Hepatology VL - 11 UR - https://doi.org/10.1002/hep.1840110218 DO - 10.1002/hep.1840110218 ID - Bhat1990 ER - TY - JOUR AU - Melegari, M. AU - Jung, M. C. AU - Schneider, R. AU - Santantonio, T. AU - Bagnulo, S. AU - Luchena, N. PY - 1991 DA - 1991// TI - Conserved core protein sequences in hepatitis B virus infected patients without anti-HBc JO - J Hepatol VL - 13 UR - https://doi.org/10.1016/0168-8278(91)90813-Q DO - 10.1016/0168-8278(91)90813-Q ID - Melegari1991 ER - TY - JOUR AU - Vergani, G. M. AU - Locasciulli, A. AU - Masera, G. AU - Alberti, A. AU - Moroni, G. AU - Tee, D. E. PY - 1981 DA - 1981// TI - Histological evidence of hepatits-B-virus infection with negative serology in children with acute leukemia who develop chronic liver disease JO - Lancet VL - 1 ID - Vergani1981 ER - TY - JOUR AU - Ellison, L. F. AU - Wilkins, K. PY - 2012 DA - 2012// TI - Canadian trends in cancer prevalence JO - Health Rep VL - 23 ID - Ellison2012 ER - TY - JOUR AU - Lunn, E. R. AU - Hoggarth, B. J. AU - Cook, W. J. PY - 2000 DA - 2000// TI - Prolonged hepatitis B surface antigenemia after vaccination JO - Pediatrics VL - 105 UR - https://doi.org/10.1542/peds.105.6.e81 DO - 10.1542/peds.105.6.e81 ID - Lunn2000 ER - TY - JOUR AU - Coursaget, P. AU - Yvonnet, B. AU - Bourdil, C. AU - Busson, Y. AU - Chotard, J. AU - N’Doye, R. PY - 1990 DA - 1990// TI - Hepatitis B surface antigen reactivity in man due to a new variant of hepatitis B virus JO - Vaccine VL - 8 UR - https://doi.org/10.1016/0264-410X(90)90208-4 DO - 10.1016/0264-410X(90)90208-4 ID - Coursaget1990 ER - TY - JOUR AU - Fiordalisi, G. AU - Primi, D. AU - Tanzi, E. AU - Magni, E. AU - Incarbone, C. AU - Zanetti, A. R. PY - 1994 DA - 1994// TI - Hepatitis B virus C gene heterogeneity in a familial cluster of anti-HBc negative chronic carriers JO - J Med Virol VL - 42 UR - https://doi.org/10.1002/jmv.1890420202 DO - 10.1002/jmv.1890420202 ID - Fiordalisi1994 ER - TY - JOUR AU - Zoulim, F. AU - Zhang, X. AU - Pichoud, C. AU - Trepo, C. PY - 1996 DA - 1996// TI - Heterogeneity of hepatitis B virus (HBV) core gene in a patient with HBV-associated cirrhosis and serum negativity for anti-HBc JO - J Hepatol VL - 24 UR - https://doi.org/10.1016/S0168-8278(96)80024-9 DO - 10.1016/S0168-8278(96)80024-9 ID - Zoulim1996 ER - TY - JOUR AU - Pescovitz, M. D. AU - Torgerson, T. R. AU - Ocheltree, E. AU - McGee, P. AU - Krause-Steinrauf, H. AU - Lachin, J. M. PY - 2011 DA - 2011// TI - Effect of rituximab on human in vivo immune responses JO - J Allergy Clin Immunol VL - 128 UR - https://doi.org/10.1016/j.jaci.2011.08.008 DO - 10.1016/j.jaci.2011.08.008 ID - Pescovitz2011 ER - TY - JOUR PY - 2013 DA - 2013// TI - CDC guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management JO - MMWR VL - 62 ID - ref18 ER - TY - JOUR AU - Phung, B. C. AU - Sogni, P. AU - Launay, O. PY - 2014 DA - 2014// TI - Hepatitis B and human immunodeficiency virus co-infection JO - World J Gastroenterol VL - 20 UR - https://doi.org/10.3748/wjg.v20.i46.17360 DO - 10.3748/wjg.v20.i46.17360 ID - Phung2014 ER -